Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo | Scientific Reports
IJMS | Free Full-Text | Inhibition of BMI-1 Induces Apoptosis through Downregulation of DUB3-Mediated Mcl-1 Stabilization | HTML
BMI-1 downregulation by PTC-209 affects stemness properties of DIPG.... | Download Scientific Diagram
BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse - ScienceDirect
PTC-209 | BMI-1 Inhibitor | MedChemExpress
Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment | Journal of Hematology & Oncology | Full Text
![PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/61dfda9a1512d58d66ac672569d4f3193a851ba9/2-Figure1-1.png "PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar")
PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar
/5BA95DA70C02F068802585F80067B610/$file/BP165815_structure.png "PTC 209 | 315704-66-6 | Biosynth Carbosynth")
PTC 209 | 315704-66-6 | Biosynth Carbosynth
PTC209, a Specific Inhibitor of BMI1, Promotes Cell Cycle Arrest and Apoptosis in Cervical Cancer Cell Lines | Anticancer Research
Polycomb group protein Bmi1 is required for the neuronal differentiation of mouse induced pluripotent stem cells
Targeting of BMI-1 with PTC-209 inhibits glioblastoma development. - Abstract - Europe PMC
Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes | Scientific Reports
Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target - Shields - 2021 - Molecular Oncology - Wiley Online Library
Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes | Scientific Reports
Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology
The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells | Blood Cancer Journal
Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology
BMI1 in the heart: Novel functions beyond tumorigenesis - eBioMedicine
Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes | Scientific Reports
Pharmacological inhibition of Bmi1 by PTC-209 impaired tumor growth in head neck squamous cell carcinoma | Cancer Cell International | Full Text
Pharmacological inhibition of Bmi1 by PTC-209 impaired tumor growth in head neck squamous cell carcinoma | Cancer Cell International | Full Text
Pharmacological inhibition of Bmi1 by PTC-209 impaired tumor growth in head neck squamous cell carcinoma | Cancer Cell International | Full Text
PTC-209 is a Specific BMI-1 Inhibitor and Impairs the Tumor Microenvironment - Network of Cancer Research
PTC-209 is a potent anti-myeloma agent that induces apoptosis. (A)... | Download Scientific Diagram
Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment | Journal of Hematology & Oncology | Full Text
PTC-209 | BMI-1 Inhibitor | MedChemExpress
